FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Brimonidine Tartrate filed by Sandoz Inc. The document does not specify the exact scope of the supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

SUPPL AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)